Skip to main content
Top

Journal of Endocrinological Investigation

Issue 4/2015

Content (13 Articles)

Short Review

MicroRNA deregulation in parathyroid tumours suggests an embryonic signature

C. Verdelli, I. Forno, V. Vaira, S. Corbetta

Original Article

Effect of a single injection of testosterone enanthate on 17β estradiol and bone turnover markers in hypogonadal male patients

V. Camozzi, G. Bonanni, A. Frigo, M. Piccolo, S. Ferasin, M. Zaninotto, M. Boscaro, G. Luisetto

Original Article

Vascular endothelial growth factor (VEGF) levels in short, GH treated children: a distinct pattern of VEGF-C in Noonan syndrome

S. Fuchs, G. Gat-Yablonski, B. Shtaif, L. Lazar, M. Phillip, Y. Lebenthal

Original Article

Heterogeneity of the growth phenotype and birth size in acid-labile subunit (ALS) deficiency

H. L. Storr, R. Prasad, I. K. Temple, L. A. Metherell, M. O. Savage, J. M. Walker

Original Article

Analysis of short- and long-term metabolic effects of growth hormone replacement therapy in adult patients with craniopharyngioma and non-functioning pituitary adenoma

E. Profka, C. Giavoli, S. Bergamaschi, E. Ferrante, E. Malchiodi, E. Sala, E. Verrua, G. Rodari, M. Filopanti, P. Beck-Peccoz, A. Spada

Original Article

Evaluation of epicardial fat tissue thickness as a marker of cardiovascular risk in patients with subclinical hypothyroidism

O. C. Santos, N. A. O. Silva, M. Vaisman, M. D. Turano, M. G. Dytz, G. A. Huber, V. B. Braulio, P. F. S. Teixeira

Original Article

Early retesting by GHRH + arginine test shows normal GH response in most children with idiopathic GH deficiency

C. Bizzarri, S. Pedicelli, B. Boscherini, G. Bedogni, M. Cappa, S. Cianfarani

Original Article

Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience

A. Arduc, F. Gokay, S. Isik, U. Ozuguz, G. Akbaba, Y. Tutuncu, D. Berker, F. K. Kucukler, Y. Aydin, S. Guler

Original Article

Effects of testosterone administration on cognitive function in hysterectomized women with low testosterone levels: a dose–response randomized trial

G. Huang, W. Wharton, T. G. Travison, M. H. Ho, C. Gleason, S. Asthana, S. Bhasin, S. Basaria

Original Article

The evaluation of Nesfatin-1 levels in patients with OSAS associated with metabolic syndrome

O. Aksu, B. Aydın, D. K. Doguç, I. Ilhan, O. Ozturk, A. Altuntas, H. Demirkan, B. K. Koroglu, M. N. Tamer

Original Article

The effect of 17β-estradiol on the expression of dipeptidyl peptidase III and heme oxygenase 1 in liver of CBA/H mice

Ž. Mačak Šafranko, S. Sobočanec, A. Šarić, N. Jajčanin-Jozić, Ž. Krsnik, G. Aralica, T. Balog, M. Abramić

Open Access Consensus Statement

Effects of treatment modalities for Graves’ hyperthyroidism on Graves’ orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement

L. Bartalena, P. E. Macchia, C. Marcocci, M. Salvi, F. Vermiglio

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine